Skeletal dysplasias: Response to growth hormone therapy

Journal of Pediatric Endocrinology and Metabolism

Volumn 9, Issue 1, 1996, Pages 31-40

  Burren, C P ^a   Werther, G A ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Growth hormone therapy; Short stature; Skeletal dysplasia

Indexed keywords

ARGININE; CLONIDINE; INSULIN; RECOMBINANT GROWTH HORMONE;

ADOLESCENT; ARTICLE; BONE DYSPLASIA; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; MALE; SHORT STATURE;

EID: 0029912875     PISSN: 0334018X     EISSN: None     Source Type: Journal    
DOI: 10.1515/JPEM.1996.9.1.31     Document Type: Article

References (16)

1. Hall BD. Approach to skeletal dysplasia. Ped Clin N Am 1992; 39: 279-305.
2. Hagenäs L. Bone clysplasias and growth hormone treatment. In: Ranke MB, Gunnarsson R, eds. Progress in Growth Hormone Therapy - 5 Years of KIGS. 1994; 256-266.
3. Appan S, Laurent S, Chapman M, Hindmarsh PC, Brook CGD. Growth and growth hormone therapy in hypochondroplasia. Acta Paediatr Scand 1990; 79: 796-803.
4. Yamate T, Kanzaki S, Tanaka H, Kubo T, Moriwake T, Inoue M, Seino Y. Growth hormone treatment in achondroplasia. J Pediatr Endocrinol 1993; 6 45-62.
5. Bridges NA, Hindmarsh PC, Brook CGD. Growth of children with hypochondroplasia treated with growth hormone for up to three years. Horm Res 1991; 36: 56-60
6. Hindmarsh PC, Bridges NA, Brook CGD. Wider indications for treatment with biosynthetic human growth hormone in children. Clin Endocrinol 1991; 34: 417-427.
7. Darendeliler F, Hindmarsh PC, Brook CGD. Non-conventional use of growth hormone: European Experience. Horm Res 1990; 33: 128-136.
8. Hammill PVV, Drizid TA, Johnson TL, et al. Physical growth: National Center for Health Statistics Percentiles Am J Clin Nutr 1979; 32: 607-629.
9. Tanner JM, Davies PSW. Clinical longitudinal standards for American children J Paediatr 1985, 107: 317-329.
10. Greulich WW, Pyle SI. Radiographic Atlas of the Skeletal Development of the Hand and Wrist. Stanford, CA: Stanford University Press, 1959.
11. Warman MJ, Abbott M, Apte SS, Hefferon T, McIntosh I. A type X collagen mutation causes Schmid metaphyseal chondrodysplasia. Nat Genet 1993; 5. 79-82.
12. Winterpacht A, Hilbert M, Schwarze U, Mundlos S, Spranger J, Zabel BU Kniest and Stickler dysplasia phenotypes caused by collagen type II gene (COL2A1) defect. Nat Genet 1993; 3. 323-326.
13. Velinov M, Slaughenhaupt SA, Stoilov I, Scott CI Jr, Gusella JF, Tsipouras P. The gene for achondroplasia maps to the telomeric region of chromosome 4p. Nat Genet 1994; 6. 314-317
14. Mullis PE, Patel MS, Brickell PM, Hindmarsh PC. Brook CGD. Growth characteristics and response to growth hormone therapy in patients with hypochondroplasia: Genetic linkage of the insulin-like growth factor 1 gene at chromosome 12q23 to the disease in a subgroup of these patients. Clin Endocrinol 1991, 34. 265-274.
15. Allen DB, Brook CGD, Bridges NA, Hindmarsh PC, Guyda HJ, Frazier D Therapeutic controversies: Growth hormone (GH) treatment of non-GH deficient subjects. J Clin Endocrinol Metab 1994; 79: 1239-1248.
16. Bridges NA, Brook CGD. Progress report: Growth hormone in skeletal dysplasia Horm Res 1994, 42: 231-234.